35,36 EMERGING AGENTS IN THE PIPELINE Several late-stage IBTs are expected to expand the weight-management landscape in 2026 or later, including CagriSema, a combination of semaglutide and cagrilintide (a long-acting amylin analogue regulating appetite and glucose)
The incidence of gastrointestinal adverse events was 72.5% with CagriSema versus 34.4% with placebo, predominantly transient and mild to moderate in severity
The peptide exhibits the sequence SDKPDMAEI EKFDKSKLKK TETQEKNPLP SKETIEQEKQ AGES with an acetylated serine residue at the N-terminus and an isoelectric point of 5.1
Once an order has entered processing, fulfillment, or shipment, it cannot be canceled or changed
Many researchers study them in combination
Designed for consistent, at-home use, this easy-to-integrate treatment supports routine scalp care with minimal effort and no added complexity